应用基因表达特征对术后感染和脓毒症进行症状前诊断
该研究纳入4385例择期手术患者,每日采集血样和临床/实验室数据,判定小组识别出154例明确术后感染(其中98例进展为脓毒症),对症状出现前3天的连续血样进行转录组分析和RT-qPCR。与术后第几天、年龄、性别和手术方式匹配的无并发症恢复患者(n=151)或无感染术后炎症患者(n=148)比较,机器学习分类在独立患者队列及匹配对照中交叉验证得出高AUC:区分感染与无并发症恢复AUC 0.871,区分感染性与非感染性全身炎症AUC 0.897,区分脓毒症与其他术后情况AUC 0.843,区分脓毒症与无并发症感染AUC 0.703。作者认为宿主生物标志物特征可能提前至临床识别前3天识别术后感染或脓毒症,若未来研究验证,这些特征对术后恶化或高危手术患者的管理具有潜在诊断价值。
要点
- 术后感染或脓毒症症状出现前3天的基因表达特征可区分感染与无并发症恢复,AUC 0.871。
- 症状前3天特征区分感染性与非感染性全身炎症的AUC为0.897。
- 症状前3天特征区分脓毒症与其他术后情况的AUC为0.843。
- 症状前3天特征区分脓毒症与无并发症感染的AUC为0.703。
- 作者认为若未来研究验证,这些特征对术后恶化或高危手术患者的管理有潜在诊断价值。
适用人群与场景
- 接受择期手术的患者,每日采集血样和临床/实验室数据。
- 判定小组识别出154例明确术后感染患者,其中98例进展为脓毒症。
- 对照为术后第几天、年龄、性别和手术方式匹配的无并发症恢复患者(n=151)或无感染术后炎症患者(n=148)。
研究设计与关键结果
- 研究类型为在4385例择期手术患者中每日采集血样和临床/实验室数据,对症状出现前3天的连续血样进行转录组分析和RT-qPCR,并与匹配对照比较。
- 症状出现前3天的基因表达特征区分感染与无并发症恢复的AUC为0.871。
- 症状出现前3天的基因表达特征区分感染性与非感染性全身炎症的AUC为0.897。
- 症状出现前3天的基因表达特征区分脓毒症与其他术后情况的AUC为0.843。
- 症状出现前3天的基因表达特征区分脓毒症与无并发症感染的AUC为0.703。
证据类型、等级与局限
- 证据类型:在择期手术患者中开展的研究,使用转录组分析和RT-qPCR,并通过机器学习分类与交叉验证在独立患者队列及匹配对照中评估。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为宿主生物标志物特征可能提前至临床识别前3天识别术后感染或脓毒症。
- 作者认为若未来研究验证,这些特征对术后恶化或高危手术患者的管理具有潜在诊断价值,并可能适用于其他患者人群。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Early accurate diagnosis of infection ± organ dysfunction (sepsis) remains a major challenge in clinical practice. Utilizing effective biomarkers to identify infection and impending organ dysfunction before the onset of clinical signs and symptoms would enable earlier investigation and intervention. To our knowledge, no prior study has specifically examined the possibility of pre-symptomatic detection of sepsis.
METHODS: Blood samples and clinical/laboratory data were collected daily from 4385 patients undergoing elective surgery. An adjudication panel identified 154 patients with definite postoperative infection, of whom 98 developed sepsis. Transcriptomic profiling and subsequent RT-qPCR were undertaken on sequential blood samples taken postoperatively from these patients in the three days prior to the onset of symptoms. Comparison was made against postoperative day-, age-, sex- and procedure- matched patients who had an uncomplicated recovery (n =151) or postoperative inflammation without infection (n =148).
RESULTS: Specific gene signatures optimized to predict infection or sepsis in the three days prior to clinical presentation were identified in initial discovery cohorts. Subsequent classification using machine learning with cross-validation with separate patient cohorts and their matched controls gave high Area Under the Receiver Operator Curve (AUC) values. These allowed discrimination of infection from uncomplicated recovery (AUC 0.871), infectious from non-infectious systemic inflammation (0.897), sepsis from other postoperative presentations (0.843), and sepsis from uncomplicated infection (0.703).
CONCLUSION: Host biomarker signatures may be able to identify postoperative infection or sepsis up to three days in advance of clinical recognition. If validated in future studies, these signatures offer potential diagnostic utility for postoperative management of deteriorating or high-risk surgical patients and, potentially, other patient populations.
参考来源
- Lukaszewski RA, Jones HE, Gersuk VH, et al. Presymptomatic diagnosis of postoperative infection and sepsis using gene expression signatures. Intensive Care Med. 2022. PMID: 35831640. doi:10.1007/s00134-022-06769-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。